BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Martini A, Gallotta A, Pontisso P, Fassina G. Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World J Hepatol 2015; 7(29): 2913-2919 [PMID: 26689503 DOI: 10.4254/wjh.v7.i29.2913]
URL: https://www.wjgnet.com/1948-5182/full/v7/i29/2913.htm
Number Citing Articles
1
Adriana Unić, Lovorka Derek, Marko Duvnjak, Leonardo Patrlj, Mislav Rakić, Milan Kujundžić, Vesna Renjić, Nikola Štoković, Petra Dinjar, Anita Jukic, Ivica Grgurević. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosisAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(3): 355 doi: 10.1177/0004563217726808
2
Jing Yu, Zhao-Juan Wang, Long-Hua Chen, Wen-Zhu Dong. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysisScandinavian Journal of Clinical and Laboratory Investigation 2017; 77(1): 8 doi: 10.1080/00365513.2016.1238504
3
Hoang Bui Huu, Nhuong Ha Thuc, Hoa Pham Thi Le, Thuy Do Thi Thanh, An Luong Bac, Claudio Tiribelli, Patrizia Pontisso, Andrea Gallotta, Laura Paneghetti, Giorgio Fassina. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patientsScandinavian Journal of Clinical and Laboratory Investigation 2018; 78(3): 204 doi: 10.1080/00365513.2018.1432072
4
Laura Paneghetti, Andrea Gallotta, Chiara Parrozzani, Giorgio Fassina. Biomarkers development for early detection of cancer: Reducing the burden of cancer in the ageing societyThe EuroBiotech Journal 2018; 2(1): 30 doi: 10.2478/ebtj-2018-0005